Surgeons anticipate new era of femtosecond laser-assisted PKP

Article

The femtosecond laser (IntraLase) holds promise for advancing penetrating keratoplasty (PKP) in the near future, said Denise Fornazari de Oliveira, MD, at the World Congress of Ophthalmology.

The femtosecond laser (IntraLase) holds promise for advancing penetrating keratoplasty (PKP) in the near future, said Denise Fornazari de Oliveira, MD, at the World Congress of Ophthalmology.

"In contrast to cataract or vitreoretinal surgery, PKP has undergone only minor refinements during the last several years. Femtosecond laser technology seems to offer the potential for moving toward minimally invasive, self-sealing, no-stitch keratoplasty, and we are looking forward to results from clinical studies using it in these procedures," said Dr. Fornazari de Oliveira of Brazil.

Through software programming, the femtosecond laser can be used to produce intrastromal lamellar, axial or pocket cuts at any diameter and at a range of depths up to 400 microns. In addition, the laser spots can be fired in a spiral or raster pattern to achieve lamellar cuts.

Potential advantages for using the femtosecond laser in penetrating keratoplasty include a reduction in the mechanical stress applied to the cornea and improved quality of the transplant edges. In addition, the geometry of the transplants can be expanded from circular patterns to other shapes that could improve transplant alignment quality.

As another benefit, the corneal cutting ability of the femtosecond laser is less hampered by optical haze compared with lasers operating at visible wavelengths. In addition, the donor tissue created with the femtosecond laser should be stronger than that produced with traditional methods as well as result in less induced astigmatism and require less suturing.

"Those features are expected to translate into faster visual rehabilitation," said Dr. Fornazari de Oliveira.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
3 experts are featured in this series.
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
3 experts are featured in this series.
Related Content
© 2025 MJH Life Sciences

All rights reserved.